Mikrobiomik Healthcare Company — Seed (estimated) · €1.1M

A €1.1M capital increase was subscribed only by existing shareholders: Orza, Seed Capital Bizkaia and 11 other partners, including family offices and founders. It funded the end of the MBK-01 Phase III trial and the planned EMA filing.

Lead unknown RoundSeed (estimated) Announced25 Sep 2023 CityDerio SectorHealthtech & Bio · Biotech / Microbiome therapeutics Source S

Something wrong? Suggest a correction →